Bacil Pharma share news and announcements
BSE: 524516Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 23 Oct 2026. Previous close ₹20.44.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹29 Cr3,172nd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 14 Oct 2026
- 1.1
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 14 Oct 2026
- −0.7%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026. The filing of 14 Oct 2026
- 0.00
- Volume, BSEVolume. Shares traded on the last trading day.
- 5,940
Last results date
The last board meeting held for results; the company has not yet given notice of the next.Bacil Pharma quarterly results
The board met on 14 Oct 2026 to consider quarterly results
Notice filed 5 Oct 2026
Bacil Pharma annual reports, presentations and earnings calls
The company's own documents, latest first.Bacil Pharma financials, year by year
Annual reports26
- Annual report, year to Mar 2026 (opens in a new tab)31 Aug 2026
- Annual report, year to Mar 2025 (opens in a new tab)5 Sep 2025
- Annual report, year to Mar 2024 (opens in a new tab)4 Sep 2024
- Annual report, year to Mar 2023 (opens in a new tab)24 Aug 2023
- Annual report, year to Mar 2022 (opens in a new tab)7 Sep 2022
21 earlier reports
- Annual report, year to Mar 2021 (opens in a new tab)3 Sep 2021
- Annual report, year to Mar 2020 (opens in a new tab)8 Sep 2020
- Annual report, year to Mar 2019 (opens in a new tab)6 Sep 2019
- Annual report, year to Mar 2018 (opens in a new tab)30 Sep 2018
- Annual report, year to Mar 2017 (opens in a new tab)5 Oct 2017
- Annual report, year to Mar 2016 (opens in a new tab)20 Oct 2016
- Annual report, year to Mar 2015 (opens in a new tab)8 Sep 2015
- Annual report, year to Mar 2014 (opens in a new tab)10 Sep 2014
- Annual report, year to Mar 2013 (opens in a new tab)6 Sep 2013
- Annual report, year to Mar 2012 (opens in a new tab)28 Dec 2012
- Annual report, year to Mar 2011 (opens in a new tab)29 Nov 2011
- Annual report, year to Mar 2010 (opens in a new tab)Filing day not known
- Annual report, year to Mar 2009 (opens in a new tab)Filing day not known
- Annual report, year to Mar 2008 (opens in a new tab)Filing day not known
- Annual report, year to Mar 2007 (opens in a new tab)Filing day not known
- Annual report, year to Mar 2006 (opens in a new tab)Filing day not known
- Annual report, year to Mar 2005 (opens in a new tab)Filing day not known
- Annual report, year to Mar 2004 (opens in a new tab)Filing day not known
- Annual report, year to Mar 2003 (opens in a new tab)Filing day not known
- Annual report, year to Mar 2002 (opens in a new tab)Filing day not known
- Annual report, year to Mar 1998 (opens in a new tab)Filing day not known
Bacil Pharma share news and announcements
542 announcements, routine notices left out, newest first. Page 1 of 11.
Oct 2026
8 Oct · Management
5 Oct · Board meeting
Meeting on 14 Oct 2026: quarterly results
Sep 2026
Aug 2026
29 Aug · Corporate action
29 Aug · Board meeting
26 Aug · Board meeting
Meeting on 29 Aug 2026: annual general meeting25 Aug · Management
25 Aug · Board meeting
18 Aug · Board meeting
Meeting on 25 Aug 20266 Aug · Board meeting
Meeting on 12 Aug 2026: quarterly results
Jul 2026
28 Jul · Announcement Under Regulation 30, LODR
9 Jul · Management
9 Jul · Announcement under Regulation 30 (LODR)-Raising of Funds
9 Jul · Board meeting
3 Jul · Board meeting
Meeting on 9 Jul 2026
Jun 2026
30 Jun · Management
26 Jun · Board meeting
23 Jun · Board meeting
Meeting on 26 Jun 2026: preferential issue of shares and rights issue
May 2026
22 May · Company Has Not Entered Any Related Party Transactions During The Half Year Ended 31St March, 2026.
11 May · Board meeting
Meeting on 22 May 2026: audited results
Apr 2026
27 Apr · Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
Feb 2026
24 Feb · Legal
24 Feb · Legal
Exchange has sought clarification from Bacil Pharma Ltd on February 24, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant ....
How the price met the news
The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.
- 9 Oct 2026Board or managers changedup 2.31%+1.2 pts vs Nifty 500market median 0.0% · five sessions −9.3% (−11.9 pts vs Nifty 500) · volume 0.6× usual · The announcement (opens in a new tab)
- 20 Jul 2026Board or managers changeddown 5.00%−5.0 pts vs Nifty 500market median 0.0% · five sessions −22.6% (−20.8 pts vs Nifty 500) · volume 1.3× usual · The announcement (opens in a new tab)
- 10 Jul 2026Board or managers changedup 0.05%−1.1 pts vs Nifty 500market median 0.0% · five sessions −3.6% (−4.3 pts vs Nifty 500) · volume 0.9× usual · The announcement (opens in a new tab)
- 2 Dec 2025Board or managers changedup 0.05%+0.5 pts vs Nifty 500market median 0.0% · five sessions −1.6% (+0.1 pts vs Nifty 500) · volume 0.6× usual · The announcement (opens in a new tab)
- 18 Aug 2025Board or managers changed0.00%−1.3 pts vs Nifty 500market median 0.0% · five sessions −11.3% (−13.9 pts vs Nifty 500) · volume 2.8× usual · The announcement (opens in a new tab)
- 11 Aug 2025Board or managers changeddown 0.21%+0.8 pts vs Nifty 500market median 0.0% · five sessions −6.9% (−6.9 pts vs Nifty 500) · volume 0.0× usual · The announcement (opens in a new tab)
- 28 Jul 2025Board or managers changed–market median 0.0% · volume 3.8× usual · The announcement (opens in a new tab)
- 27 Feb 2025Board or managers changeddown 0.98%−0.5 pts vs Nifty 500market median 0.0% · five sessions −8.6% (−7.8 pts vs Nifty 500) · volume 0.1× usual · The announcement (opens in a new tab)
- 27 Sep 2024Board or managers changedup 1.98%+2.0 pts vs Nifty 500market median 0.0% · five sessions +10.3% (+14.2 pts vs Nifty 500) · volume 0.1× usual · The announcement (opens in a new tab)
- 2 Sep 2024Board or managers changedup 1.99%+1.9 pts vs Nifty 500market median 0.0% · five sessions +10.3% (+11.4 pts vs Nifty 500) · volume 5.6× usual · The announcement (opens in a new tab)
4 earlier announcements
- 29 Aug 2024Board or managers changedup 1.96%+1.9 pts vs Nifty 500market median 0.0% · five sessions +10.3% (+9.7 pts vs Nifty 500) · volume 0.9× usual · The announcement (opens in a new tab)
- 18 Sep 2023Board or managers changedup 4.86%+4.8 pts vs Nifty 500market median 0.0% · five sessions +27.1% (+28.9 pts vs Nifty 500) · volume 0.0× usual · The announcement (opens in a new tab)
- 22 Mar 2023Board or managers changeddown 1.01%−1.3 pts vs Nifty 500market median 0.0% · five sessions −6.0% (−4.7 pts vs Nifty 500) · volume 0.0× usual · The announcement (opens in a new tab)
- 28 Apr 2020Board or managers changedup 4.76%+3.9 pts vs Nifty 500market median 0.0% · five sessions +25.9% (+27.0 pts vs Nifty 500) · volume 2.7× usual · The announcement (opens in a new tab)
Figures filed again
Lines the company later filed with a different value, rupee lines in ₹ crore and per-share lines in rupees.
| Line | Period | Accounts | First filed | Filed again | Change. The value filed again less the value first filed, as a per cent of the first. | First filed on | Filed again on |
|---|---|---|---|---|---|---|---|
| Cash and cash equivalents | At Mar 2025 | Standalone | 2.86 | 2.86 | 0.0% | 12 Jun 2025 (opens in a new tab) | 24 Jun 2025 (opens in a new tab) |
| Financial assets due within a year | At Mar 2025 | Standalone | 2.91 | 2.86 | −1.7% | 12 Jun 2025 (opens in a new tab) | 24 Jun 2025 (opens in a new tab) |
| Assets turning to cash within a year | At Mar 2025 | Standalone | 2.91 | 2.91 | 0.0% | 12 Jun 2025 (opens in a new tab) | 24 Jun 2025 (opens in a new tab) |
| Total assets | At Mar 2025 | Standalone | 25.60 | 25.60 | 0.0% | 12 Jun 2025 (opens in a new tab) | 24 Jun 2025 (opens in a new tab) |
| Financial liabilities due within a year | At Mar 2025 | Standalone | 0.16 | 0.17 | +2.5% | 12 Jun 2025 (opens in a new tab) | 24 Jun 2025 (opens in a new tab) |
| Liabilities due within a year | At Mar 2025 | Standalone | 0.16 | 0.17 | +2.5% | 12 Jun 2025 (opens in a new tab) | 24 Jun 2025 (opens in a new tab) |
| Total liabilities | At Mar 2025 | Standalone | 0.17 | 0.17 | +0.1% | 12 Jun 2025 (opens in a new tab) | 24 Jun 2025 (opens in a new tab) |
| Total equity and liabilities | At Mar 2025 | Standalone | 25.60 | 25.60 | 0.0% | 12 Jun 2025 (opens in a new tab) | 24 Jun 2025 (opens in a new tab) |